BPC-157 has not completed that process and is not FDA-approved for any human indication
The rd1 mouse is a common animal model used to study RP in which the expression of over 60 genes, related to proliferation, apoptosis, and transcription, is modified via a mutation in the phosphodiesterase-6 gene, which affects the metabolism of cyclic guanosine monophosphate
The pivotal STEP (Semaglutide Treatment Effect in People with obesity) clinical trial programme, which included thousands of participants, did not identify ovarian cysts as a recognised adverse effect of semaglutide
Having said this, it is noted that graphene is a thin, light, flexible, and highly resistant nanomaterial [1,2]
Late stage treatment with arimoclomol delays disease progression and prevents protein aggregation in the SOD1 mouse model of ALS